Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
776.75 | -49.18% | -28.32% | 699,389.88 | 0.67% | 2.63% |
|
NYSE:JNJ
Johnson & Johnson
|
151.18 | 0% | 0% | 364,311 | 3.43% | 2.71% |
|
NYSE:MRK
Merck
|
128.80 | -8.38% | 5.03% | 326,254.03 | 2.38% | -19.03% |
|
NYSE:PFE
Pfizer
|
27.18 | 14.31% | 46.24% | 153,907.87 | 6.56% | -9.31% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
402.14 | 8.37% | 16.96% | 103,936.84 | 0% | 30.14% |
|
NasdaqGS:REGN
Regeneron Pharmaceuticals
|
903.48 | -23.45% | -16.93% | 97,472.39 | 0% | 13.9% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.21 | 61.08% | 71.38% | 89,618.1 | 5.46% | 13.54% |
|
NYSE:ZTS
Zoetis
|
158.50 | 38.96% | 56.16% | 72,426.13 | 1.09% | 11.57% |
|
NYSE:BAX
Baxter International Inc
|
40.34 | 59.62% | 83.75% | 20,547.06 | 2.87% | -3.14% |
|
NasdaqGS:VTRS
Viatris Inc
|
11.63 | 1.95% | 12.16% | 13,740.18 | 4.15% | -8.55% |
|
NasdaqGS:UTHR
United Therapeutics
|
255.14 | -6.89% | 2.89% | 11,319.67 | 0% | 5.22% |
|
NYSE:CTLT
Catalent
|
56.00 | -57.3% | -6.83% | 10,107.41 | 0% | -10.41% |
|
NasdaqGS:CYTK
Cytokinetics
|
63.37 | 0% | 0% | 6,424.74 | 0% | 0% |
|
NasdaqGS:IONS
Ionis Pharmaceuticals
|
43.01 | -,154.22% | -,147.1% | 6,017.6 | 0% | 0% |
|
NasdaqGS:BCPC
Balchem
|
143.82 | -0.56% | 9% | 4,561.9 | 0.56% | 5.85% |
|
NYSE:PRGO
Perrigo Co PLC
|
32.90 | 39.65% | 63.25% | 4,425.95 | 3.38% | -15.93% |
|
NasdaqGS:MDGL
Madrigal Pharmaceuticals
|
210.59 | 0% | 0% | 4,342.48 | 0% | 0% |
|
NasdaqGS:NEOG
Neogen
|
12.25 | 135.45% | 235.73% | 2,670.77 | 0% | -1.7% |
|
LSE:INDV
Indivior PLC
|
14.28 | -23.61% | -1.68% | 1,952.43 | 0% | -2.7% |
|
NasdaqCM:CORT
Corcept Therapeutics
|
23.88 | -33.03% | -8.53% | 2,479.63 | 0% | 2.03% |
